Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.9.2.2 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.9.2.2 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.9.2.2 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.9.2.2 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.9.2.2 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.9.2.2 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EW.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
EW.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EW.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
EW.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EW.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EW.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EW.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EW.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBF.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBF.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBF.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBF.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBF.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBF.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBF.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HH.8.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HH.8.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HH.8.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HH.8.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HH.8.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HH.8.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HH.8.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HH.8.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.19EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.19ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.19ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.19EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.19EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FM.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
FM.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FM.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
FM.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FM.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FM.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FM.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FM.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FK.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FK.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FK.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FK.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used